Symptomatic heterozygous X-Linked myotubular myopathy female patient with a large deletion at Xq28 and decrease expression of normal allele.

X-linked myotubular myopathy (XLMTM; OMIM 310400) is a centronuclear congenital muscular disorder of X-linked recessive inheritance. Although female carriers are typically asymptomatic, affected heterozygous females have been described. Here, we describe the case of a sporadic female patient with suspicion of centronuclear myopathy and a heterozygous large deletion at Xq28 encompassing the MAMLD1 , MTM1 , MTMR1 , CD99L2 , and HMGB3 genes. The deletion was first detected using a custom next generation sequencing (NGS)-based multigene panel and finally characterized by comparative genomic hybridization array and multiplex ligation probe assay techniques. In this patient we have confirmed, by MTM1 mRNA quantification, a MTM1 gene expression less than the expected 50 percent in patient muscle. The significant 20% reduction in MTM1 mRNA expression in muscle, precludes low level of the normal myotubularin protein as the cause of the phenotype in this heterozygous female. We have also found that BIN1 expression in patient muscle biopsy was significantly increased, and postulate that BIN1 expression will be increased in XLMTM patient muscle as an attempt to maintain muscle function. • Manifestations in recessive X-linked diseases carriers has been linked to a skewed inactivation of the X chromosome. • We reported a female patient with XLMTM and a MTM1 gene expression less than 50 percent in patient muscle. • The genetic diagnosis of female patients with XLMTM should be aided by XCI analysis, histological studies, and RNA analysis. • BIN1 expression, increased in patient muscle, will be increased in XLMTM patient as an attempt to maintain muscle function. [ABSTRACT FROM AUTHOR]